Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Finasteride may cause breast enlargement, low testosterone a risk factor.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The study found stem cells in minor salivary glands that can differentiate and are involved in tumor formation when exposed to tobacco.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.